The U.S. Drug Supply Chain Security Act requires drugs to be traced as they move through the supply chain. Pharmacies must:
- Only accept prescription drugs accompanied by three pieces of product tracing documentation: transaction information, transaction history, and transaction statement.
- Store the product tracing documentation received in paper or electronic format for six years. Pharmacies may negotiate third-party agreements with business partners to store such documentation.
- Generate and provide the three-part product tracing documentation with the transaction if a prescription drug is transferred to a trading partner unless the prescription drug is transferred from a pharmacy to another pharmacy for dispensing to a specific patient.
HRG’s service relieves the burden from the dispenser, providing not only a repository solution, but also proactive monitoring of transactions to identify any anomalies that should be investigated. This functionality provides peace of mind and limits the need to add additional staff to oversee the legitimacy of supply-chain transactions.
Beginning November 2020, pharmacies must only accept pharmaceutical products that include 2D serialized product identifiers, except for items otherwise grandfathered or not covered under the Drug Supply Chain regulation. HRG’s solution not only assists pharmacies in creating standard operating procedures (SOPs) to address this requirement, but also can work with the pharmacy to implement scanning equipment and processes to comply. Additionally, the SOP will help pharmacies formally address quarantine practices for suspect items and the steps to take if counterfeiting or adulterated drugs are discovered in the supply chain.
HRG’s proven application allows the exchange of information so the details of Rx transactions are safely stored, extracted, and reported as needed under the law.
“HRG’s approach is to work directly with our retail pharmacy members and offer a solution that considers the unique needs of community pharmacists. Additionally, their reputation and commitment to independent pharmacy has been unwavering,” says Kurt Proctor, NCPA’s SVP of strategic initiatives.